Point72 Hong Kong LTD Abbott Laboratories Put Options Transaction History

Point72 Hong Kong LTD

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $154,816 - $179,248	1,600 Added 6.84%	25,000 $2.42 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $520,556 - $629,187	5,100 Added 27.87%	23,400 $2.54 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $889,356 - $1.08 Million	7,800 Added 74.29%	18,300 $2.17 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $358,143 - $438,526	-3,100 Reduced 22.79%	10,500 $1.48 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $5.61 Million - $6.21 Million	-48,100 Reduced 77.96%	13,600 $1.61 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $5.9 Million - $6.95 Million	55,800 Added 945.76%	61,700 $7.15 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $642,156 - $756,556	5,900 New	5,900 $707,000

3,184

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.